VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 350,000 Value ($000) $1,974 Avg Close — Range —
Q3 2024
Shares 350,000 Value ($000) $1,694 Avg Close — Range —
Q2 2024
Shares 350,000 Value ($000) $1,708 Avg Close — Range —
Q1 2024
Shares 350,000 Value ($000) $4,648 Avg Close — Range —
Q4 2023
Shares 350,000 Value ($000) $4,879 Avg Close — Range —
Q3 2023
Shares 350,000 Value ($000) $4,641 Avg Close — Range —
Q2 2023
Shares 350,000 Value ($000) $6,563 Avg Close — Range —
Q1 2023
Shares 350,000 Value ($000) $5 Avg Close — Range —
Q4 2022
Shares 350,000 Value ($000) $7 Avg Close — Range —
Q3 2022
Shares 600,000 Value ($000) $20,610 Avg Close — Range —
Q2 2022
Shares 700,710 Value ($000) $10,707 Avg Close — Range —
Q1 2022
Shares 700,710 Value ($000) $15,990 Avg Close — Range —
Q4 2021
Shares 1,109,224 Value ($000) $40,897 Avg Close — Range —
Q3 2021
Shares 709,224 Value ($000) $32,667 Avg Close — Range —
Q2 2021
Shares 709,224 Value ($000) $40,594 Avg Close — Range —